The 2018 National Cancer Research Institute (NCRI) Cancer Conference was held in Glasgow, UK, from the 4–6 November. Follow this page for expert interviews and stay up-to-date as breakthrough clinical trial results for oncolytic viruses are discussed, pressing issues on treatment challenges are explored and promising evidence for emerging biomarkers presented.

NCRI 2018

NCRI 2018

The 2018 National Cancer Research Institute (NCRI) Cancer Conference was held in Glasgow, UK, from the 4–6 November. Follow this page for expert interviews and stay up-to-date as breakthrough clinical trial results for oncolytic viruses are discussed, pressing issues on treatment challenges are explored and promising evidence for emerging biomarkers presented.

Determining the top ten research priorities in cancer survivorship 2:19
Determining the top ten research priorities in cancer survivorship
Galina Velikova
The gut microbiome: role in causing and detecting colorectal cancer 3:40
The gut microbiome: role in causing and detecting colorectal cancer
Paul O'Toole
Learning cancer screening programs: why are they needed? 2:29
Learning cancer screening programs: why are they needed?
Mette Kalager
The NCRI: an opportunity for patients and students to gain invaluable skills 1:14
The NCRI: an opportunity for patients and students to gain invaluable skills
Max Williamson
Understanding the complexity of cancer treatment 3:10
Understanding the complexity of cancer treatment
Martin Christlieb
Targeting hypoxia in tumors with combination therapy 1:44
Targeting hypoxia in tumors with combination therapy
Kaye Williams
Why attend a medical congress: a patient and student perspective 2:56
Why attend a medical congress: a patient and student perspective
Max Williamson
Hypoxia in the tumor microenvironment drives radiation resistance 1:11
Hypoxia in the tumor microenvironment drives radiation resistance
Kaye Williams
Improving public health: the link between air pollution and cancer is as strong as ever 4:06
Improving public health: the link between air pollution and cancer is as strong as ever
John Cherrie
Future uses of ctDNA measurements: changing the treatment landscape 3:07
Future uses of ctDNA measurements: changing the treatment landscape
Pierre-Jean Lamy
Reactivating the host immune response against cancer: new genetic discoveries 2:21
Reactivating the host immune response against cancer: new genetic discoveries
Sergio Quezada
The current discrepancies in cancer care 4:13
The current discrepancies in cancer care
Nancy Keating
ctDNA measurement via liquid biopsy: improving cancer detection and diagnosis 2:12
ctDNA measurement via liquid biopsy: improving cancer detection and diagnosis
Pierre-Jean Lamy
Advances in immune regulation and tumor immunotherapy 3:28
Advances in immune regulation and tumor immunotherapy
Sergio Quezada
Benefits of the scientist-patient interaction 2:33
Benefits of the scientist-patient interaction
Martin Christlieb
Digital pathology: improving the landscape of cancer diagnosis 3:15
Digital pathology: improving the landscape of cancer diagnosis
Manuel Salto-Tellez
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals